Infectious Disease · Respiratory Infections
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Influenza presents with the abrupt onset of high-grade fever, myalgias, headache, and non-productive cough.
The gold standard for diagnosis is the reverse transcription-polymerase chain reaction (RT-PCR) assay due to its high sensitivity and specificity.
Oseltamivir is the neuraminidase inhibitor of choice for treatment and should be initiated within 48 hours of symptom onset to reduce duration.
Secondary bacterial pneumonia, most commonly caused by *Staphylococcus aureus* or *Streptococcus pneumoniae*, is the most frequent serious complication.
The annual inactivated influenza vaccine is recommended for all individuals aged 6 months and older.
Antigenic drift refers to minor mutations in hemagglutinin and neuraminidase that necessitate annual vaccine updates, whereas antigenic shift involves major reassortment leading to pandemics.
Reye syndrome, characterized by fulminant hepatic failure and encephalopathy, is a rare but life-threatening complication associated with aspirin use in children with influenza.
Vignette unlocked
A 34-year-old male presents to the urgent care clinic in February with a 24-hour history of sudden-onset high fever (103.2°F), severe diffuse myalgias, and a dry, hacking cough. He reports that his symptoms began abruptly while at work yesterday. Physical examination reveals erythematous pharynx without exudates and clear lungs on auscultation. His pulse oximetry is 98% on room air.
What is the most appropriate next step in management for this patient?
Initiate oral oseltamivir therapy
The patient's presentation of abrupt onset systemic symptoms during peak influenza season is classic for influenza; since he is within the 48-hour window, neuraminidase inhibitor therapy is indicated.
Full handout
High yield triage
Etiology / Epidemiology
Acute viral respiratory illness caused by Orthomyxoviridae; peaks in winter months among unvaccinated individuals.
Clinical Manifestations
Abrupt onset of high fever, myalgias, and non-productive cough; systemic symptoms predominate over URI symptoms.
Diagnosis
RT-PCR is the gold standard; rapid antigen tests have high specificity but low sensitivity.
Treatment
Oseltamivir is the first-line treatment if initiated within 48 hours of symptom onset.
Prognosis
Most recover in 1 week; secondary bacterial pneumonia (often Staphylococcus aureus) is the most common fatal complication.
Full handout
Epidemiology & Etiology
Influenza A and B are the primary human pathogens, with Influenza A causing more severe outbreaks due to antigenic shift. Transmission occurs via respiratory droplets. High-risk groups include the elderly, pregnant women, and those with chronic cardiopulmonary disease.
Pertinent Anatomy
The virus targets the ciliated respiratory epithelium of the upper and lower airways. Destruction of these cells impairs the mucociliary escalator, predisposing patients to secondary bacterial superinfection.
Pathophysiology
Viral entry is mediated by hemagglutinin binding to sialic acid receptors. Viral release is facilitated by neuraminidase. The systemic inflammatory response, driven by cytokine release, accounts for the hallmark myalgias and malaise.
Clinical Manifestations
Presentation is characterized by the abrupt onset of fever, headache, and severe myalgias. Unlike the common cold, systemic symptoms are more prominent than nasal congestion. Red flags include dyspnea, hypoxia, or altered mental status, suggesting primary viral pneumonia or secondary bacterial infection.
Diagnosis
The RT-PCR assay is the gold standard due to superior sensitivity and specificity. Rapid influenza diagnostic tests (RIDTs) are useful for quick screening but carry a high rate of false negatives. Testing is generally reserved for patients requiring hospitalization or those at high risk for complications.
Treatment
Oseltamivir is the drug of choice for treatment and post-exposure prophylaxis. Therapy must be started within 48 hours to reduce symptom duration by ~24 hours. Avoid aspirin in children due to the risk of Reye syndrome. Supportive care includes analgesics and hydration.
Prognosis
While self-limiting, secondary bacterial pneumonia is a major cause of morbidity. Monitor for worsening respiratory status or a 'second-hit' fever after initial improvement, which suggests a bacterial superinfection. Annual vaccination remains the most effective preventive measure.
Differential Diagnosis
COVID-19: loss of taste/smell
Common Cold: gradual onset, prominent rhinorrhea
Streptococcal Pharyngitis: exudative tonsillitis, lack of cough
Bacterial Pneumonia: focal consolidation on CXR
RSV: more common in infants/elderly with wheezing